Carbyne Equity Partners has agreed to invest into UAB Biomapas

21.10.2024 Carbyne Equity Partners has agreed to invest into UAB Biomapas

TGS Baltic client, Carbyne Equity Partners, a leading European private equity firm, has signed to acquire a strategic partnership with UAB Biomapas, a leading provider of clinical research, pharmacovigilance (PV), regulatory affairs (RA), medical information (MI), and quality assurance (QA) services across Europe.

This collaboration between the existing shareholders and new investors marks a significant milestone in Biomapas' journey, ensuring sustainable growth and expansion as the company continues to build on its 20-year legacy.

Carbyne Equity Partners Managing Partner, Alexander Winterling, highlighted their confidence in Biomapas' potential, stating the firm’s commitment to supporting the company in both strengthening its core offerings and pursuing new market opportunities.

The company's strategy will focus on strengthening its core services, exploring new market opportunities, and exploiting identified M&A opportunities to drive growth further.

Carbyne Equity Partners was advised by TGS Baltic, represented by Marius Matonis, Indrė Vickaitė-Liatukė, Dalia Tamašauskienė-Žilienė, Domantas Vilys, and Rūta Tikuišytė, who advised the client in all transaction related matters. 

Due diligence team for this transaction consisted of Rokas Kazakevičius, Meda Stankutė, Domantas Mažrimas, Morta Putaitė, Evelina Savickaitė, Indrė Mažeikaitė, Violeta Mačiulytė, Neda Baublytė, Renaldas Paškevičius, Viktorija Jančiūraitė, Eglė Mikšytė, and Inesa Grybova.